BRI3BP
BRI3-binding protein
Also known as: BNAS1, BRI3B_HUMAN, HCCR-2, HCCRBP-3, KG19
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WY22
- Gene
- BRI3BP
- Ensembl
- ENSG00000184992
- Chromosome
- 12
- Canonical length
- 251 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
251 residues, UniProt reviewed canonical sequence.
>Q8WY22|BRI3BP
1 MGARASGGPL ARAGLLLLLL LLLLLGLLAP GAQGARGRGG AEKNSYRRTV NTFSQSVSSL
61 FGEDNVRAAQ KFLARLTERF VLGVDMFVET LWKVWTELLD VLGLDVSNLS QYFSPASVSS
121 SPARALLLVG VVLLAYWFLS LTLGFTFSVL HVVFGRFFWI VRVVLFSMSC VYILHKYEGE
181 PENAVLPLCF VVAVYFMTGP MGFYWRSSPS GPSNPSNPSV EEKLEHLEKQ VRLLNIRLNR
241 VLESLDRSKD KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BRI3BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 20 nTPM
- small intestine: 18 nTPM
- tonsil: 15 nTPM
- colon: 15 nTPM
- rectum: 14 nTPM
- lymph node: 13 nTPM
Single-cell type
- late spermatids: 313 nCPM
- monocyte progenitors: 129 nCPM
- enteric transient amplifying cells: 85 nCPM
- neutrophil progenitors: 82 nCPM
- colonocytes: 73 nCPM
- megakaryocyte progenitors: 70 nCPM
Immune cell
- eosinophil: 13 nTPM
- plasmacytoid DC: 4.2 nTPM
- basophil: 4.1 nTPM
- classical monocyte: 2.2 nTPM
- neutrophil: 2.2 nTPM
- myeloid DC: 1.7 nTPM
Brain region
- basal ganglia: 28 nTPM
- cerebral cortex: 28 nTPM
- pons: 27 nTPM
- midbrain: 27 nTPM
- spinal cord: 26 nTPM
- white matter: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.2
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Negative regulator of p53/TP53
- BRI3-binding protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BRI3BP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BRI3BP as an antibody target. Whether an autoantibody or antibody against BRI3BP could matter depends on whether native BRI3BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BRI3BP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BRI3BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...